×
About 652 results

ALLMedicine™ Antithrombin Deficiency Center

Research & Reviews  321 results

Antithrombin Dose Optimization in Extracorporeal Membrane Oxygenation in Infants.
https://doi.org/10.1097/MAT.0000000000001340
ASAIO Journal (American Society for Artificial Internal O... Liviskie CJ, Lahart MA et. al.

Feb 2nd, 2021 - Anticoagulation in extracorporeal membrane oxygenation (ECMO) is challenging, with significant morbidity and mortality associated with thrombotic complications. Unfractionated heparin (UFH) is commonly used, which depends on native antithrombin (A...

Type II antithrombin deficiency caused by a novel missense mutation (p.Leu417Gln) in a ...
https://doi.org/10.1097/MBC.0000000000000973
Blood Coagulation & Fibrinolysis : an International Journ... Liu S, Wang H et. al.

Nov 16th, 2020 - o explore the phenotype and genotype of a hereditary antithrombin deficient Chinese family. Functional and molecular analysis of the proband and his family members was performed. Online bioinformatics software was used to predict the pathogenicity...

Direct Oral Anticoagulants in Select Patients With Hypercoagulable Disorders.
https://doi.org/10.1177/1060028020968551
The Annals of Pharmacotherapy; Valanejad SM, Davis KA

Oct 26th, 2020 - To summarize the literature assessing the safety and efficacy of direct oral anticoagulants (DOACs) for the acute treatment and secondary prevention of venous thromboembolism (VTE) in select patients with hypercoagulable disorders. An electronic P...

Antithrombin p.Thr147Ala: The First Founder Mutation in People of African Origin Respon...
https://doi.org/10.1055/s-0040-1716531
Thrombosis and Haemostasis; Orlando C, de la Morena-Barrio B et. al.

Sep 13th, 2020 - Hereditary antithrombin deficiency is a rare autosomal-dominant disorder predisposing to recurrent venous thromboembolism (VTE). To date, only two founder mutations have been described. We investigated the antithrombin p.Thr147Ala variant, found i...

Direct Oral Anticoagulants in Antithrombin Deficiency: Initial Experience in a Single C...
https://doi.org/10.1055/s-0040-1715647
Thrombosis and Haemostasis; Bhoelan BS, Mulder R et. al.

Aug 30th, 2020 - Direct Oral Anticoagulants in Antithrombin Deficiency: Initial Experience in a Single Center.|2020|Bhoelan BS,Mulder R,Lukens MV,Meijer K,|

see more →

Drugs  1 results see all →

Clinicaltrials.gov  327 results

Antithrombin Dose Optimization in Extracorporeal Membrane Oxygenation in Infants.
https://doi.org/10.1097/MAT.0000000000001340
ASAIO Journal (American Society for Artificial Internal O... Liviskie CJ, Lahart MA et. al.

Feb 2nd, 2021 - Anticoagulation in extracorporeal membrane oxygenation (ECMO) is challenging, with significant morbidity and mortality associated with thrombotic complications. Unfractionated heparin (UFH) is commonly used, which depends on native antithrombin (A...

Type II antithrombin deficiency caused by a novel missense mutation (p.Leu417Gln) in a ...
https://doi.org/10.1097/MBC.0000000000000973
Blood Coagulation & Fibrinolysis : an International Journ... Liu S, Wang H et. al.

Nov 16th, 2020 - o explore the phenotype and genotype of a hereditary antithrombin deficient Chinese family. Functional and molecular analysis of the proband and his family members was performed. Online bioinformatics software was used to predict the pathogenicity...

Direct Oral Anticoagulants in Select Patients With Hypercoagulable Disorders.
https://doi.org/10.1177/1060028020968551
The Annals of Pharmacotherapy; Valanejad SM, Davis KA

Oct 26th, 2020 - To summarize the literature assessing the safety and efficacy of direct oral anticoagulants (DOACs) for the acute treatment and secondary prevention of venous thromboembolism (VTE) in select patients with hypercoagulable disorders. An electronic P...

Antithrombin p.Thr147Ala: The First Founder Mutation in People of African Origin Respon...
https://doi.org/10.1055/s-0040-1716531
Thrombosis and Haemostasis; Orlando C, de la Morena-Barrio B et. al.

Sep 13th, 2020 - Hereditary antithrombin deficiency is a rare autosomal-dominant disorder predisposing to recurrent venous thromboembolism (VTE). To date, only two founder mutations have been described. We investigated the antithrombin p.Thr147Ala variant, found i...

Direct Oral Anticoagulants in Antithrombin Deficiency: Initial Experience in a Single C...
https://doi.org/10.1055/s-0040-1715647
Thrombosis and Haemostasis; Bhoelan BS, Mulder R et. al.

Aug 30th, 2020 - Direct Oral Anticoagulants in Antithrombin Deficiency: Initial Experience in a Single Center.|2020|Bhoelan BS,Mulder R,Lukens MV,Meijer K,|

see more →

News  3 results

Pregnancy-Linked VTE Risk Varies by Type of Thrombophilia
https://www.medpagetoday.com/obgyn/pregnancy/68853

Oct 27th, 2017 - Absolute risk of pregnancy-associated venous thromboembolism (VTE) varied depending on the type of thrombophilia among women with a family history of VTE, a systematic review and meta-analysis found. While all thrombophilias increased the risk of ...

New FDA Orphan Drugs: CDX-110, ATryn, ISIS 333611
https://www.medscape.com/viewarticle/567860

Dec 20th, 2007 - December 21, 2007 -- The US Food and Drug Administration (FDA) has granted orphan drug designation to CDX-110 for the treatment of glioblastoma multiforme, ATryn for the treatment of hereditary antithrombin deficiency, and ISIS 333611 for the trea...

Q.Are oral contraceptives safe for women with a thrombophilic defect?
https://www.mdedge.com/obgyn/article/62659/qare-oral-contraceptives-safe-women-thrombophilic-defect
Gerson Weiss, MD

Fast Track Women with a thrombophilic deficiency who used OCs developed VTE at a younger age than their non–OC-using counterparts A. No.

see more →